Study Results Encourage Discussion of Therapeutic Options for VWD Patients with Menorrhagia
While the majority of women with von Willebrand disease (VWD) will experience heavy menstrual bleeding (HMB) often associated negative impacts on overall health and quality of life, available data relevant to effective treatment is limited.
Gynecologists Have Significant Part to Play in Shrinking Diagnostic Gaps
FDA Approves First-Ever Nonprescription Oral Contraceptive
Inequities in Thrombosis and Hemostasis Lab Testing the Focus of Illustrated Review
Continued Conversation on the State of Access to Women’s Health Care
Coexisting Women's Health Conditions
Bleeding disorder symptoms can sometimes be worsened or changed by other conditions that often affect women, such as endometriosis or polycystic ovary syndrome
NHF Addresses Potential Contraception Bans
NHF Responds to Roe v. Wade Reversal
Starting the Conversation with Hajar Abusief
Starting the Conversation with Dr. Bethany Samuelson Bannow
Dr. Bethany Samuelson Bannow sat down with NHF to discuss her co-authored Twitter account, Dr. Period Hackers.
Starting the Conversation with Dr. Marybec Griffin
Public Health for Blood Disorders Series Now Available Online!
VWD: The Realities of Your Period
NBDF provides free quality education on issues that matter to the bleeding disorders community. This video is on vwd: the realities of your period
Clinical Study and New Website to Focus on von Willebrand Disease and Pregnancy
New Data Analysis Sheds Light on Bleeding Patterns in Young VWD Patients
Study Looks at Neuraxial Anesthesia and Postpartum Complications in Hemophilia
May 2021 Wednesday Webinars
NHF's Wednesday Webinars for May 2021 will focus on Women's Health Month, featuring topics of interest to both patients and healthcare providers who are interested in issues faced by women with inheritable blood disorders.
Pregnancy and Childbirth in Women with Bleeding Disorders
Pregnancy and childbirth for women with bleeding disorders take extra planning and care. Come learn from an expert and community member about issues women with bleeding disorders face when pregnant and giving birth, and how to advocate for the care you need.
Women Bleed Too
Women and girls with bleeding disorders often deal with particular issues and taboos related to diagnosis, symptoms, access to care. In this session, an expert who works to improve the quality of life for women and girls with bleeding disorders will discuss essential information on the challenges of getting a diagnosis and accessing care and treatment. In addition, an affected individual will share their experience as a woman with a bleeding disorder.
Wednesday Webinar February 2021 Speakers
New Guidelines on the Diagnosis and Management of VWD
Men? I Feel Like a WOMAN... with a Bleeding Disorder
Expanding your PT evaluation skills to include the unique considerations for women with bleeding disorders.
Small Study Looks at Use of Epidural Analgesia During Labor in VWD Type 1
A research abstract presented at the recent Thrombosis & Haemostasis Summit of North America 2020 Virtual Conference suggested that epidural analgesia may be a safe option for pregnant women with von Willebrand disease (VWD) type 1, provided clotting factors are maintained at certain levels.
Public Health for Women & Girls
NOT AVAILABLE FOR CREDIT
After a successful public health offering at NHF’s 2019 BDC, NHF decided to collaborate with several national blood disorder advocacy organizations to deliver two public health sessions for chapters and consumers. This session will address women’s issues in public health and was created by the National Blood Clot Alliance, Center for Inherited Bleeding Disorders, Cooley’s Anemia Foundation, Foundation for Women and Girls with Blood Disorders, NHF, and HFA.
Gynecologic Management for Female with Bleeding Disorders
*ANCC
Moderator:
Kelly Tickle, MSN, APN, PPCNP-BC
Pediatric Nurse Practitioner, Children’s Healthcare of Atlanta
Speaker:
Kalinda Woods, MD, FACOG
Assistant Professor, Department of Gynecology and Obstetrics
Emory University School of Medicine
By the end of this session, the participant should be better able to: